Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infection-induced glucose starvation triggers NINJ1-dependent macrophage lysis and Candida escape.

Nature communications·2026
Same author

Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet-induced obesity.

Clinical & translational immunology·2026
Same author

Mitochondrial fission mediates an evolutionarily conserved antibacterial defense response.

Science immunology·2026
Same author

ROS breaks the cofilin lock on NLRP3.

Nature immunology·2026
Same author

NeuO-mediated O-acetylation of uropathogenic <i>Escherichia coli</i> K1 capsule enhances resistance to phage and neutrophil killing.

Journal of bacteriology·2026
Same author

NLRP1 under pressure: An overview of the NLRP1 inflammasome as a sensor of cellular stress.

Molecular cell·2025
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

The inflammasomes.

Kate Schroder1, Jurg Tschopp

  • 1Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.

Cell
|March 23, 2010
PubMed
Summary
This summary is machine-generated.

Inflammasomes are key immune sensors for infection and stress. This review details their normal function, disease dysregulation, and links to cell death pathways like pyroptosis and autophagy.

More Related Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

Related Experiment Videos

Last Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Inflammasomes are critical innate immune sensors that activate pro-inflammatory cytokines, crucial for defense against pathogens and cellular stress.
  • Dysregulated inflammasome activity is linked to various human inflammatory diseases, underscoring its importance in immune response regulation.
  • Understanding inflammasome pathways is vital for developing targeted therapies for inflammatory conditions.

Purpose of the Study:

  • To provide a comprehensive review of inflammasome function and its dysregulation in disease.
  • To discuss the agonists and activation mechanisms of key inflammasomes, including NLRP1, NLRP3, IPAF, and AIM2.
  • To examine regulatory mechanisms and emerging connections between inflammasomes, pyroptosis, and autophagy.

Main Methods:

  • Literature review and synthesis of existing research on inflammasome biology.
  • Detailed discussion of molecular mechanisms underlying inflammasome activation and regulation.
  • Exploration of the interplay between inflammasomes and cellular processes like pyroptosis and autophagy.

Main Results:

  • Identification of diverse agonists and activation pathways for specific inflammasomes (NLRP1, NLRP3, IPAF, AIM2).
  • Elucidation of regulatory mechanisms that control inflammasome activation thresholds.
  • Establishment of emerging links between inflammasome signaling and programmed cell death (pyroptosis) and cellular recycling (autophagy).

Conclusions:

  • Inflammasome pathways are central to innate immunity, with precise regulation essential for health.
  • Aberrant inflammasome activity contributes significantly to the pathogenesis of inflammatory diseases.
  • Further research into inflammasome regulation and its crosstalk with pyroptosis and autophagy holds therapeutic potential for inflammatory disorders.